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WD 大鼠的受损各项功能有一定程度的恢复。此外，我们还研究了 WD 病早期代




















The quantitative measurement of the dynamic multi-parametric metabolic 
response of a living system to pathophysiological stimuli or genetic modification is 
termed “metabolomics”. The 1H NMR spectroscopy has been shown to be one of the 
most important analytical techniques used in metabolomics, as it can detect many 
endogenous metabolites rapidly and reproducibly without tendentiousness or 
separation. Nuclear magnetic resonance (NMR)-based metabonomics was applied to 
study the hyperthyroidism and Wilson’s disease by analyzing metabolic profiling of 
serum and urine. The purpose of this study is to determine an array of characteristic 
metabolites in serum and urine samples from hyperthyroidism and Wilson’s disease 
based on NMR spectroscopy. The metabolic changes of familial hyperthyroidism 
patients were investigated. Besides, we have used the copper-overloaded rats model 
for Wilson’s disease (WD) combining with the 1H NMR spectroscopy to characterize 
the alteration of metabolic profiles for the early stage, the later stage of disease and 
the penicillamine treated group. The main works are summarized as follows: 
1. The concepts of NMR-based metabolomics were introduced briefly. An 
evaluation of progress to date in application of NMR-based metabolomics for the 
understanding of pathogenic mechanism was reviewed.  
2.  The collection, preparation and analysis by NMR spectroscopy of serum, 
urine and tissue samples were summarized. The physical and chemical properties, 
endogenous metabolites, sample collection, preservation, and NMR experimental 
preparation of these biological samples were also discussed. 
3. High resolution NMR spectroscopy combined with multivariate statistical 
analysis was applied to investigate the urine and serum of hyperthyroidism patients. 
Results showed that the elevated levels of choline, glucose and declined levels of 
VLDL, LDL, cholesterol, lactate, glycoprotein and alanine were detected in serum 














showed increased levels of glucose, citrate, taurine and creatinine as well as decreased 
levels of hippurate, trimethylamine-N-oxide, formate and succinate. Furthermore, the 
metabolic profiling of familial hyperthyroidism patients was also investigated.   
4. 1H NMR spectroscopy in combination with multivariate statistical analysis 
was applied to explore the metabolic profiles from WD model , the early stage of WD 
model and penicillamine -treated rats using biofluids. WD rats showed increased 
levels of lactate, creatine, creatinine, leucine, isoleucine and decreased levels of 
glucose, TMAO, myo-inositol and glycine in serum, as well as increased excretion of 
urinary acetone, creatine, creatinine and Kreb’s cycle intermediates, ketone bodies, 
and decreased levels of urinary glucose, glycine. Significantly elevated levels of 
lactate in serum and urinary acetate indicated carbohydrate metabolism and energy 
metabolism disturbance in Wilson’s disease. Increased excretion of ketone bodies, 
altered alanine and glucose metabolites suggested that the liver was possibly impaired 
in WD rats. Elevated level of creatine and creatinine in serum and urine were 
observed in WD rats, which could be biomarkers for kidney injury. The decrease of 
choline and its metabolite betaine in serum and urine indicate a disturbance in choline 
metabolism. In contrast to the WD group, the metabolite profile of the penicillamine 
(PA) treated group were affected obviously. These perturbations indicate that the 
PA-treated group was recovery from WD group in a certain extent. In addition, the 
metabolic phenotypes of early stage of Wilson’s disease rats model were investigated 
using 1H NMR spectroscopy together with pattern recognition to determine its 
characteristic metabolites. The study shows the potential application of NMR-based 
metabonomic analysis in biochemical profile and providing further insight into the 
molecular mechanism underlying the disorder. 
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